The Executive Summary: World Market for Prescription Respiratory Drugs

Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market.

The report from which this Executive Summary is compiled is World Market for Prescription Respiratory Drugs, and the full study abstract is as follows:

The global market for prescription respiratory drugs encompasses a wide variety of products that treat both common everyday respiratory illnesses as well as serious chronic conditions such as COPD. Technological developments and improved delivery methods have given many health professionals a wider range of products to treat patients with respiratory diseases and have expanded the market for respiratory pharmaceuticals.

This comprehensive study of the market for prescription pharmaceutical products to treat respiratory illness examines six distinct drug segments:

• Anti-inflammatories, Inhaled Corticosteroids
• Mast Stabilizers, Leukotriene Modifiers, and Other Biologics
• Antihistamines, Decongestants, and Antitussives
• Bronchodilators
• Lung Fluid Replacement and Mucokinetic Agents
• Other Respiratory Drugs

Each section provides particulars on the currently available pharmaceutical products in that class, the development pipeline (including developer and development stage), and detailed market data on the segment, including:

• Historical revenue performance 2000-2005
• Revenue projections through 2010
• Geographic revenue breakdown (U.S. vs non-U.S.)
• Epidemiology of the relevant conditions
• Revenues and market shares of the leading suppliers.